Singapore, Singapore

Ju Lin Teo

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Siemens Medical Instruments Pte. Ltd.. Active years: 2009-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ju Lin Teo. Retrieved from https://idiyas.com/inventor/ju-lin-teo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ju Lin Teo

Introduction: Ju Lin Teo, a visionary inventor hailing from Singapore, SG, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Ju Lin Teo's latest patents include a cutting-edge AI-powered healthcare device designed to revolutionize patient care, as well as a sustainable energy solution that aims to tackle environmental challenges.

Career Highlights: With a career spanning over two decades, Ju Lin Teo has established himself as a pioneer in the tech industry, holding multiple patents and receiving recognition for his inventive spirit.

Collaborations: Throughout his career, Ju Lin Teo has collaborated with leading research institutions and tech companies to bring his ideas to life, fostering a culture of innovation and creativity in the industry.

Conclusion: Ju Lin Teo's relentless pursuit of innovation and his passion for creating solutions to real-world problems make him a true trailblazer in the world of technology. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…